• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

早期类风湿关节炎的缓解:预测治疗反应。

Remission in early rheumatoid arthritis: predicting treatment response.

机构信息

Department of Rheumatology, King's College London School of Medicine, Weston Education Centre, King's College London, London SE5 9RS, UK.

出版信息

J Rheumatol. 2012 Mar;39(3):470-5. doi: 10.3899/jrheum.110169. Epub 2012 Jan 15.

DOI:10.3899/jrheum.110169
PMID:22247360
Abstract

OBJECTIVE

Optimizing therapeutic strategies to induce remission requires an understanding of the initial features predicting remission. Currently no suitable model exists. We aim to develop a remission score using predictors of remission in early rheumatoid arthritis (RA).

METHODS

We used a dataset from a UK randomized controlled trial that evaluated intensive treatment with conventional combination therapy, to develop a predictive model for 24-month remission. We studied 378 patients in the trial who received 24 months' treatment. Our model was validated using data from a UK observational cohort (Early RA Network, ERAN). A group of 194 patients was followed for 24 months. Remission was defined as 28-joint Disease Activity Score < 2.6. Logistic regression models were used to estimate the associations between remission and potential baseline predictors.

RESULTS

Multivariate logistic regression analyses showed age, sex, and tender joint count (TJC) were independently associated with 24-month remission. The multivariate remission score developed using the trial data correctly classified 80% of patients. These findings were replicated using ERAN. The remission score has high specificity (98%) but low sensitivity (13%). Combining data from the trial and ERAN, we also developed a simplified remission score that showed that younger men with a TJC of 5 or lower were most likely to achieve 24-month remission. Remission was least likely in older women with high TJC. Rheumatoid factor, rheumatoid nodules, and radiographic damage did not predict remission.

CONCLUSION

Remission can be predicted using a score based on age, sex, and TJC. The score is relevant in clinical trial and routine practice settings.

摘要

目的

优化诱导缓解的治疗策略需要了解预测缓解的初始特征。目前尚无合适的模型。我们旨在使用早期类风湿关节炎(RA)缓解的预测因子开发缓解评分。

方法

我们使用了来自英国随机对照试验的数据,该试验评估了常规联合治疗的强化治疗,以开发 24 个月缓解的预测模型。我们研究了试验中接受 24 个月治疗的 378 例患者。我们使用英国观察性队列(早期 RA 网络,ERAN)的数据验证了我们的模型。对 194 例患者进行了 24 个月的随访。缓解定义为 28 关节疾病活动评分<2.6。使用逻辑回归模型估计缓解与潜在基线预测因子之间的关联。

结果

多变量逻辑回归分析显示年龄、性别和压痛关节计数(TJC)与 24 个月缓解独立相关。使用试验数据开发的多变量缓解评分正确分类了 80%的患者。使用 ERAN 复制了这些发现。缓解评分具有高特异性(98%)但低灵敏度(13%)。结合试验和 ERAN 的数据,我们还开发了一个简化的缓解评分,表明 TJC 为 5 或更低的年轻男性最有可能实现 24 个月的缓解。缓解最不可能发生在 TJC 较高的老年女性中。类风湿因子、类风湿结节和放射学损伤不能预测缓解。

结论

可以使用基于年龄、性别和 TJC 的评分来预测缓解。该评分在临床试验和常规实践环境中具有相关性。

相似文献

1
Remission in early rheumatoid arthritis: predicting treatment response.早期类风湿关节炎的缓解:预测治疗反应。
J Rheumatol. 2012 Mar;39(3):470-5. doi: 10.3899/jrheum.110169. Epub 2012 Jan 15.
2
Joint damage in rheumatoid arthritis progresses in remission according to the Disease Activity Score in 28 joints and is driven by residual swollen joints.类风湿关节炎的关节损伤在缓解期会根据28个关节的疾病活动评分进展,且由残留的肿胀关节驱动。
Arthritis Rheum. 2011 Dec;63(12):3702-11. doi: 10.1002/art.30634.
3
Comparison of the long-term outcome for patients with rheumatoid arthritis with persistent moderate disease activity or disease remission during the first year after diagnosis: data from the ESPOIR cohort.比较诊断后第一年持续存在中度疾病活动或疾病缓解的类风湿关节炎患者的长期结局:来自 ESPOIR 队列的数据。
Ann Rheum Dis. 2015 Apr;74(4):724-9. doi: 10.1136/annrheumdis-2013-204178. Epub 2014 Jan 7.
4
Disease remission and sustained halting of radiographic progression with combination etanercept and methotrexate in patients with rheumatoid arthritis.类风湿关节炎患者使用依那西普与甲氨蝶呤联合治疗后疾病缓解及影像学进展持续停止
Arthritis Rheum. 2007 Dec;56(12):3928-39. doi: 10.1002/art.23141.
5
Modern treatment strategies in rheumatoid arthritis.类风湿关节炎的现代治疗策略
Dan Med Bull. 2011 Nov;58(11):B4320.
6
The effect of different remission definitions on identification of predictors of both point and sustained remission in rheumatoid arthritis treated with anti-TNF therapy.不同缓解定义对接受抗TNF治疗的类风湿关节炎患者中短期缓解和持续缓解预测因素识别的影响。
J Rheumatol. 2014 Aug;41(8):1607-13. doi: 10.3899/jrheum.131451. Epub 2014 Jul 15.
7
Can remission in rheumatoid arthritis be assessed without laboratory tests or a formal joint count? possible remission criteria based on a self-report RAPID3 score and careful joint examination in the ESPOIR cohort.类风湿关节炎的缓解能否在不进行实验室检查或正式关节计数的情况下进行评估?基于自我报告的 RAPID3 评分和 ESPOIR 队列中仔细的关节检查的可能缓解标准。
J Rheumatol. 2013 Apr;40(4):386-93. doi: 10.3899/jrheum.121059. Epub 2013 Feb 1.
8
Good clinical response, remission, and predictors of remission in rheumatoid arthritis patients treated with tumor necrosis factor-alpha blockers: the GISEA study.肿瘤坏死因子-α阻滞剂治疗类风湿关节炎患者的良好临床反应、缓解情况及缓解预测因素:GISEA研究
J Rheumatol. 2007 Aug;34(8):1670-3. Epub 2007 Jul 1.
9
Joint damage progression in patients with rheumatoid arthritis in clinical remission: do biologics perform better than synthetic antirheumatic drugs?类风湿关节炎临床缓解患者的关节损伤进展:生物制剂比合成抗风湿药物效果更好吗?
J Rheumatol. 2014 Aug;41(8):1576-82. doi: 10.3899/jrheum.130767. Epub 2014 Jul 15.
10
Clinical and serological predictors of remission in rheumatoid arthritis are dependent on treatment regimen.类风湿关节炎缓解的临床和血清学预测指标取决于治疗方案。
J Rheumatol. 2014 Jul;41(7):1298-303. doi: 10.3899/jrheum.131401.

引用本文的文献

1
Development of machine learning models for predicting non-remission in early RA highlights the robust predictive importance of the RAID score-evidence from the ARCTIC study.用于预测早期类风湿关节炎(RA)未缓解情况的机器学习模型的开发凸显了RAID评分强大的预测重要性——来自北极研究的证据。
Front Med (Lausanne). 2025 Feb 12;12:1526708. doi: 10.3389/fmed.2025.1526708. eCollection 2025.
2
Towards Personalized Medicine in Rheumatoid Arthritis.迈向类风湿关节炎的个性化医疗
Open Access Rheumatol. 2024 May 18;16:89-114. doi: 10.2147/OARRR.S372610. eCollection 2024.
3
Impact of the combined presence of erosions and ACPA on rheumatoid arthritis disease activity over time: results from the METEOR registry.
联合存在侵蚀和 ACPA 对类风湿关节炎疾病活动度随时间的影响:来自 METEOR 登记处的结果。
RMD Open. 2019 Jul 30;5(2):e000969. doi: 10.1136/rmdopen-2019-000969. eCollection 2019.
4
Clinical predictors of remission and low disease activity in Latin American early rheumatoid arthritis: data from the GLADAR cohort.拉丁美洲早期类风湿关节炎缓解和低疾病活动度的临床预测因素:来自 GLADAR 队列的数据。
Clin Rheumatol. 2019 Oct;38(10):2737-2746. doi: 10.1007/s10067-019-04618-x. Epub 2019 Jun 3.
5
Prediction of primary non-response to methotrexate therapy using demographic, clinical and psychosocial variables: results from the UK Rheumatoid Arthritis Medication Study (RAMS).利用人口统计学、临床和心理社会变量预测甲氨蝶呤治疗的原发性无反应:来自英国类风湿关节炎药物研究(RAMS)的结果。
Arthritis Res Ther. 2018 Jul 13;20(1):147. doi: 10.1186/s13075-018-1645-5.
6
Predicting methotrexate resistance in rheumatoid arthritis patients.预测类风湿关节炎患者对甲氨蝶呤的耐药性。
Inflammopharmacology. 2018 Jun;26(3):699-708. doi: 10.1007/s10787-018-0459-z. Epub 2018 Mar 12.
7
Window of opportunity to achieve major outcomes in early rheumatoid arthritis patients: how persistence with therapy matters.在早期类风湿关节炎患者中实现主要治疗效果的机会窗口:治疗持续性的重要性
Arthritis Res Ther. 2015 Jul 11;17(1):177. doi: 10.1186/s13075-015-0697-z.
8
ACPA-positive and ACPA-negative rheumatoid arthritis differ in their requirements for combination DMARDs and corticosteroids: secondary analysis of a randomized controlled trial.抗环瓜氨酸肽抗体阳性和阴性的类风湿性关节炎在联合使用改善病情抗风湿药和皮质类固醇方面的需求存在差异:一项随机对照试验的二次分析
Arthritis Res Ther. 2014 Jan 16;16(1):R13. doi: 10.1186/ar4439.
9
Comparison of remission criteria in a tumour necrosis factor inhibitor treated rheumatoid arthritis longitudinal cohort: patient global health is a confounder.肿瘤坏死因子抑制剂治疗的类风湿关节炎纵向队列中缓解标准的比较:患者整体健康状况是一个混杂因素。
Arthritis Res Ther. 2013 Dec 24;15(6):R221. doi: 10.1186/ar4421.
10
Rheumatoid factor positivity is associated with increased joint destruction and upregulation of matrix metalloproteinase 9 and cathepsin k gene expression in the peripheral blood in rheumatoid arthritic patients treated with methotrexate.类风湿因子阳性与接受甲氨蝶呤治疗的类风湿关节炎患者关节破坏增加以及外周血中基质金属蛋白酶9和组织蛋白酶K基因表达上调有关。
Int J Rheumatol. 2013;2013:457876. doi: 10.1155/2013/457876. Epub 2013 Nov 14.